Viva Biotech Executive and Leadership Team

Cheney Mao, the Chief Executive Officer & President at Viva Biotech, directs the company's overall strategic vision and operational execution. This leadership role involves guiding Viva Biotech's mission to provide structure-based drug discovery services to a global clientele within the biotechnology and pharmaceutical sectors. Mao oversees the integration of scientific innovation with business development, ensuring the company remains at the forefront of preclinical stage drug development. The Chief Executive Officer & President champions the company's commitment to advancing therapeutic solutions through cutting-edge technology and client-focused services. By fostering a culture of scientific excellence and operational efficiency, Cheney Mao drives the company's expansion and market impact, solidifying Viva Biotech's position as a key partner for pharmaceutical innovation worldwide.

Xiong Wei, the Group Chief Financial Officer at Viva Biotech, manages the company's financial strategy and fiscal operations. This executive position involves overseeing all aspects of financial planning, resource allocation, and investment management to support Viva Biotech's global drug discovery services. The Group Chief Financial Officer ensures robust financial controls and reporting mechanisms are in place, facilitating sustainable growth and operational efficiency. Wei's responsibilities extend to optimizing financial performance and securing capital necessary for the expansion of preclinical stage drug development initiatives. By providing strategic financial guidance, Xiong Wei underpins the company's ability to serve biotechnology and pharmaceutical partners effectively, reinforcing Viva Biotech's commitment to innovation and client success worldwide.

Derek Ren, the Executive Director and President at Viva Biotech, drives operational excellence and strategic market engagement for the company's structure-based drug discovery platform. This leadership position focuses on expanding Viva Biotech's reach and impact within the global biotechnology and pharmaceutical industries. Ren oversees key operational functions, ensuring seamless delivery of preclinical stage drug development services to clients worldwide. The Executive Director and President champions the company's mission to accelerate therapeutic innovation through integrated scientific solutions. By fostering strong client relationships and optimizing service delivery, Derek Ren contributes significantly to Viva Biotech's growth and its reputation as a trusted partner in drug discovery, reinforcing the company's commitment to advancing global health outcomes.

Xueheng Cheng, the Chief Technology Officer at Viva Biotech, architects the technological framework underpinning the company's integrated drug discovery platform. This critical role focuses on advancing the structure-based drug discovery services offered to biotechnology and pharmaceutical clients globally. The Chief Technology Officer spearheads research and development initiatives, ensuring Viva Biotech leverages state-of-the-art methodologies for preclinical stage drug development. Cheng's leadership drives the continuous enhancement of the platform's capabilities, enabling more efficient and effective drug candidate identification. By overseeing technological innovation, Xueheng Cheng ensures Viva Biotech maintains its competitive edge and delivers superior scientific solutions, directly supporting the advancement of novel therapeutics for unmet medical needs worldwide.